非小细胞肺癌接受调强放疗或被动散射质子治疗同步化疗后的局部区域失败模式
比较非小细胞肺癌患者接受被动散射质子治疗(PSPT)与调强光子放疗(IMRT)同步化疗后的局部区域失败模式,并分析自适应计划的影响。212例中152例(72%)无失败;60例失败者中局部失败27例(45%)、边缘失败23例(38%)、区域失败10例(17%)。IMRT与PSPT的边缘失败率无差异(12% vs 9%,log-rank P=.558)。
要点
- IMRT与PSPT的局部失败、边缘失败、区域失败模式无差异。
- 边缘失败唯一独立预测因素为T3-4分期。
- 大肿瘤及使用PSPT独立预测需要自适应计划。
核心结论
- IMRT与PSPT在局部失败、边缘失败、区域失败模式上无差异。
- 质子治疗更常需要自适应计划,所用自适应计划技术未损害肿瘤控制。
- 大肿瘤对放化疗的反应可预测较好的生存。
研究设计与样本
- 研究将治疗模拟CT扫描和剂量分布与显示复发的图像配准。
- 局部失败定义为内靶区(ITV)内失败;边缘失败定义为ITV与计划靶区(PTV)加10mm边缘(PTV+10mm)之间失败;区域失败定义为PTV+10mm以外失败。
- 所有患者每周进行治疗中4维CT模拟和验证计划。
- 若验证计划显示方案指定剂量分布有偏差则制定自适应计划,并记录这些患者的失败位置。
- 共分析212例患者。
主要发现
- 212例中152例(72%)无失败。
- 60例失败患者中,27例(45%)为局部失败(ITV内),23例(38%)为边缘失败(ITV与PTV+10mm之间),10例(17%)为区域失败(PTV外>10mm)。
- 边缘失败率在IMRT组为16/136(12%),PSPT组为7/76(9%),两组无差异(log-rank P=.558)。
- Cox比例风险分析显示边缘失败唯一独立预测因素为T3-4状态。
- 大肿瘤和使用PSPT独立预测需要自适应计划。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We compared differences in patterns of locoregional failure, and the influence of adaptive planning on those patterns, in patients who received passive scattering proton therapy (PSPT) versus intensity modulated photon therapy (IMRT) for non-small cell lung cancer. METHODS AND MATERIALS: Treatment simulation computed tomography scans and dose distributions were registered with images depicting the recurrence. Local failure (LF) was defined as failure within the internal target volume (ITV); marginal failure (MF) as failure between the ITV and planning target volume (PTV) plus a 10-mm margin (PTV+10mm); and regional failure (RF) as outside the PTV+10mm. Weekly during-treatment 4-dimensional computed tomography simulation and verification plans were obtained for all patients. Adaptive plans were developed if the verification plan showed deviations in protocol-specified dose distribution, and failure locations were recorded for those patients as well. RESULTS: Of the 212 patients analyzed, most (152 [72%]) had no failure; of the 60 patients with failure, 27 (45%) had LF (within the ITV), 23 (38%) had MF (between the ITV and PTV+10mm), and 10 (17%) had RF (>10 mm outside the PTV). MF rates were no different for IMRT patients (16 of 136 [12%]) or PSPT patients (7 of 76 [9%], log-rank P = .558). The only independent predictor of MF on Cox proportional hazards analysis was T3-4 status. Large tumors and use of PSPT independently predicted the need for adaptive planning. Although 5-year overall survival rates were poorer for patients with large tumors versus small tumors (P < .001), the rates were similar for patients with large tumors who received adaptive planning versus small tumors. CONCLUSIONS: No differences in LF, MF, or RF patterns were found for IMRT versus PSPT. Proton therapy more often required adaptive planning, and the techniques used for adaptive planning did not compromise tumor control. Response to chemoradiation by larger tumors predicted favorable survival.
引用
- Yang P, Xu T, Gomez DR, et al. Patterns of Local-Regional Failure After Intensity Modulated Radiation Therapy or Passive Scattering Proton Therapy With Concurrent Chemotherapy for Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2018. PMID: 30165127. doi:10.1016/j.ijrobp.2018.08.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。